Please use this identifier to cite or link to this item:
Title: Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.
Authors: Núñez-Torres, R
Macías, J
Rivero-Juarez, A
Neukam, K
Merino, D
Téllez, F
Merchante, N
Gómez-Mateos, J
Rivero, A
Pineda, J A
Real, L M
Group for the Study of Viral Hepatitis (HEPAVIR) of The Andalusian Society of Infectious Diseases (SAEI)
Keywords: HIV;fat mass and obesity-associated gene;fatty liver disease;genetics;polymorphisms
metadata.dc.subject.mesh: Adolescent
Aged, 80 and over
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
Cross-Sectional Studies
Elasticity Imaging Techniques
Fatty Liver
Genetic Predisposition to Disease
Genotyping Techniques
HIV Infections
Middle Aged
Polymorphism, Single Nucleotide
Young Adult
Issue Date: 24-Jan-2017
Abstract: Fatty liver disease (FLD) is frequently observed in HIV-infected patients. Obesity and type 2 diabetes mellitus (T2DM) are strongly associated with FLD. Because genetic variants within the fat mass and obesity-associated (FTO) gene have been associated with both pathologies, our aim was to evaluate the association of single nucleotide polymorphisms (SNPs) within the FTO, previously related to obesity or T2DM, with FLD in HIV-infected patients. FLD was defined as a value of the controlled attenuation parameter (CAP) ≥ 238 dB/m, obtained by transient elastography. Four SNPs within FTO intron 1 (rs11642841, rs8050136, rs9939609 and rs9940128) were genotyped in 421 individuals using a custom Golden Gate protocol. The results were replicated in a validation sample consisting of a further 206 HIV-infected patients. Multivariate logistic regression analyses were conducted in the entire population. Three SNPs (rs8050136, rs9939609 and rs9940128) were associated with FLD, with rs9940128 showing the strongest association. This polymorphism also showed an association with FLD in the validation sample. In total, rs9940128 was genotyped in 627 HIV-infected patients, including 267 (42.6%) FLD-diagnosed individuals. The frequency of FLD among rs9940128 AA carriers was 55.7% (63 of 113 individuals) and that in patients without this genotype was 39.7% (204 of 514 individuals) [P = 0.009; adjusted odds ratio 1.88; 95% confidence interval (CI) 1.17-3.01]. Variations within FTO may be predictors of FLD in HIV-infected patients independently of metabolic factors.
metadata.dc.identifier.doi: 10.1111/hiv.12489
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.